DMG deals Saatchis China another blow

Johnson & Johnson JV Xian Janssen has handed its second account to DMG, upset stomach remedy Motilium, its biggest and best selling brand carrying a monitored spend of around Rmb200 million (US$25 million). <BR><BR> DMG secured the brand in a pitch against incumbent Saatchi & Saatchi, after taking Xian Janssen's Gyno-Daktarin from Saatchis at the end of last year. It is not known what prompted the pitch but Motilium is competing in a tough marketing environment where it is outspent by key rivals while copycat marketing coupled with strict rules governing OTC advertising makes differentiation difficult. <BR><BR> "The client is looking for fresh ideas and something that can relate to the consumer," DMG said.

Please sign in below or access limited articles a month after free, fast registration.

 If you don’t yet have an account, you can register for free to unlock additional content. For full access to everything we offer, view our subscription plans.

Register for free

✓ Access limited free articles each month

✓ Email bulletins – top industry news and insights delivered straight to your inbox

Subscribe

✓ Unlimited access to all Campaign Asia content

✓ Real-world campaign case studies and career insights

✓ Exclusive reports, industry news, and annual features